1. Home
  2. ARDX vs DCOM Comparison

ARDX vs DCOM Comparison

Compare ARDX & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • DCOM
  • Stock Information
  • Founded
  • ARDX 2007
  • DCOM 1864
  • Country
  • ARDX United States
  • DCOM United States
  • Employees
  • ARDX N/A
  • DCOM N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • DCOM Major Banks
  • Sector
  • ARDX Health Care
  • DCOM Finance
  • Exchange
  • ARDX Nasdaq
  • DCOM Nasdaq
  • Market Cap
  • ARDX 1.2B
  • DCOM 1.4B
  • IPO Year
  • ARDX 2014
  • DCOM 1996
  • Fundamental
  • Price
  • ARDX $4.91
  • DCOM $32.23
  • Analyst Decision
  • ARDX Buy
  • DCOM Strong Buy
  • Analyst Count
  • ARDX 7
  • DCOM 5
  • Target Price
  • ARDX $10.58
  • DCOM $34.20
  • AVG Volume (30 Days)
  • ARDX 5.0M
  • DCOM 356.5K
  • Earning Date
  • ARDX 02-20-2025
  • DCOM 01-23-2025
  • Dividend Yield
  • ARDX N/A
  • DCOM 3.09%
  • EPS Growth
  • ARDX N/A
  • DCOM N/A
  • EPS
  • ARDX N/A
  • DCOM 1.50
  • Revenue
  • ARDX $251,849,000.00
  • DCOM $313,737,000.00
  • Revenue This Year
  • ARDX $168.07
  • DCOM N/A
  • Revenue Next Year
  • ARDX $16.66
  • DCOM $33.41
  • P/E Ratio
  • ARDX N/A
  • DCOM $21.48
  • Revenue Growth
  • ARDX 87.57
  • DCOM N/A
  • 52 Week Low
  • ARDX $4.32
  • DCOM $17.29
  • 52 Week High
  • ARDX $10.13
  • DCOM $37.60
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 44.85
  • DCOM 52.34
  • Support Level
  • ARDX $4.98
  • DCOM $31.54
  • Resistance Level
  • ARDX $6.07
  • DCOM $32.73
  • Average True Range (ATR)
  • ARDX 0.37
  • DCOM 1.07
  • MACD
  • ARDX -0.01
  • DCOM 0.27
  • Stochastic Oscillator
  • ARDX 4.92
  • DCOM 86.47

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About DCOM Dime Community Bancshares Inc.

Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities.

Share on Social Networks: